176 related articles for article (PubMed ID: 28893623)
21. A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone.
Garrido M; Peng HM; Yoshimoto FK; Upadhyay SK; Bratoeff E; Auchus RJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():1-10. PubMed ID: 24508512
[TBL] [Abstract][Full Text] [Related]
22. [Abiraterone acetate: a novel therapeutic option in hormone-refractory prostate cancer].
Turitto G; Di Bisceglie M; Moraca L; Sasso N; Sepede C; Suriano A; Romito S
Recenti Prog Med; 2012 Feb; 103(2):74-8. PubMed ID: 22430753
[TBL] [Abstract][Full Text] [Related]
23. Interaction of 17α-hydroxylase, 17(20)-lyase (CYP17A1) inhibitors - abiraterone and galeterone - with human sterol 14α-demethylase (CYP51A1).
Masamrekh R; Kuzikov A; Veselovsky A; Toropygin I; Shkel T; Strushkevich N; Gilep A; Usanov S; Archakov A; Shumyantseva V
J Inorg Biochem; 2018 Sep; 186():24-33. PubMed ID: 29807244
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of halogenated pregnanes, mechanistic probes of steroid hydroxylases CYP17A1 and CYP21A2.
Yoshimoto FK; Desilets MC; Auchus RJ
J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):38-50. PubMed ID: 22001566
[TBL] [Abstract][Full Text] [Related]
25. Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1.
Li A; Yadav R; White JK; Herroon MK; Callahan BP; Podgorski I; Turro C; Scott EE; Kodanko JJ
Chem Commun (Camb); 2017 Mar; 53(26):3673-3676. PubMed ID: 28304025
[TBL] [Abstract][Full Text] [Related]
26. Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase.
Loke S; Stoll A; Machalz D; Botrè F; Wolber G; Bureik M; Parr MK
Front Endocrinol (Lausanne); 2021; 12():633785. PubMed ID: 34149610
[TBL] [Abstract][Full Text] [Related]
27. Dirty deeds done dirt cheap: sensitization of prostate cancer cells to abiraterone treatment using hydroxylated polychlorinated biphenyls.
Daragan G; Hoffmann J; Vasko T; Mustea A; Burchardt M; Kraus T; Stope MB; Ziegler P
Invest New Drugs; 2020 Apr; 38(2):541-545. PubMed ID: 31292837
[TBL] [Abstract][Full Text] [Related]
28. Structural and Functional Evaluation of Clinically Relevant Inhibitors of Steroidogenic Cytochrome P450 17A1.
Petrunak EM; Rogers SA; Aubé J; Scott EE
Drug Metab Dispos; 2017 Jun; 45(6):635-645. PubMed ID: 28373265
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancer.
Pinto-Bazurco Mendieta MA; Negri M; Jagusch C; Müller-Vieira U; Lauterbach T; Hartmann RW
J Med Chem; 2008 Aug; 51(16):5009-18. PubMed ID: 18672868
[TBL] [Abstract][Full Text] [Related]
30. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.
Yamaoka M; Hara T; Hitaka T; Kaku T; Takeuchi T; Takahashi J; Asahi S; Miki H; Tasaka A; Kusaka M
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):115-28. PubMed ID: 22249003
[TBL] [Abstract][Full Text] [Related]
31. Abiraterone acetate: a novel drug for castration-resistant prostate carcinoma.
Nandha R
J Postgrad Med; 2012; 58(3):203-6. PubMed ID: 23023354
[TBL] [Abstract][Full Text] [Related]
32. 1alpha,25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells.
Lundqvist J; Norlin M; Wikvall K
Biochim Biophys Acta; 2010 Sep; 1801(9):1056-62. PubMed ID: 20420936
[TBL] [Abstract][Full Text] [Related]
33. Fine-mapping of the substrate specificity of human steroid 21-hydroxylase (CYP21A2).
Stoll A; Loke S; Joseph JF; Machalz D; de la Torre X; Botrè F; Wolber G; Bureik M; Parr MK
J Steroid Biochem Mol Biol; 2019 Nov; 194():105446. PubMed ID: 31404637
[TBL] [Abstract][Full Text] [Related]
34. The steroid metabolite 16(β)-OH-androstenedione generated by CYP21A2 serves as a substrate for CYP19A1.
Neunzig J; Milhim M; Schiffer L; Khatri Y; Zapp J; Sánchez-Guijo A; Hartmann MF; Wudy SA; Bernhardt R
J Steroid Biochem Mol Biol; 2017 Mar; 167():182-191. PubMed ID: 28065637
[TBL] [Abstract][Full Text] [Related]
35. HIV Drug Efavirenz Inhibits CYP21A2 Activity with Possible Clinical Implications.
Malikova J; Zingg T; Fingerhut R; Sluka S; Grössl M; Brixius-Anderko S; Bernhardt R; McDougall J; Pandey AV; Flück CE
Horm Res Paediatr; 2019; 91(4):262-270. PubMed ID: 31256164
[TBL] [Abstract][Full Text] [Related]
36. [CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway].
Audenet F; Murez T; Ripert T; Villers A; Neuzillet Y
Prog Urol; 2013 Oct; 23 Suppl 1():S9-15. PubMed ID: 24314739
[TBL] [Abstract][Full Text] [Related]
37. CYP21A2 expression is localized in the developing distal epithelium of the human perinatal lung and is compatible with in situ production and intracrine actions of active glucocorticoids.
Bouhaddioui W; Provost PR; Tremblay Y
J Steroid Biochem Mol Biol; 2016 Oct; 163():12-9. PubMed ID: 27004467
[TBL] [Abstract][Full Text] [Related]
38. In vitro interactions of abiraterone, erythromycin, and CYP3A4: implications for drug-drug interactions.
Masamrekh RA; Kuzikov AV; Haurychenka YI; Shcherbakov KA; Veselovsky AV; Filimonov DA; Dmitriev AV; Zavialova MG; Gilep AA; Shkel TV; Strushkevich NV; Usanov SA; Archakov AI; Shumyantseva VV
Fundam Clin Pharmacol; 2020 Feb; 34(1):120-130. PubMed ID: 31286572
[TBL] [Abstract][Full Text] [Related]
39. Why human cytochrome P450c21 is a progesterone 21-hydroxylase.
Mizrachi D; Wang Z; Sharma KK; Gupta MK; Xu K; Dwyer CR; Auchus RJ
Biochemistry; 2011 May; 50(19):3968-74. PubMed ID: 21446712
[TBL] [Abstract][Full Text] [Related]
40. Agents that target androgen synthesis in castration-resistant prostate cancer.
Ferraldeschi R; de Bono J
Cancer J; 2013; 19(1):34-42. PubMed ID: 23337755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
